Gerhard Ehninger, Prof. Dr. med.
Chief Executive Officer at Cellex Gesellschaft für Zellgewinnung mbH, founding shareholder of GEMoaB Monoclonals GmbH, founding shareholder of Cellex Gesellschaft für Zellgewinnung mbH
Co-founder of the German Bone Marrow Donor Registry (DKMS)
Member of the Board of Directors at Rhön Klinikum AG
Speaker SFB 655 “From Cells to Tissues” (Collaborative Research Center for Stem Cell Research) 2005-2017
Former Head of Hematology & Oncology, University Hospital “Carl Gustav Carus”, Technical University Dresden, Germany
Former President of the German Society of Hematology and Oncology (DGHO)
More than 700 scientific publications in peer-reviewed journals
Michael Bachmann, Prof. Dr. rer. nat.
Founding shareholder of GEMoaB Monoclonals GmbH
Director of the Institute for Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden, Germany
Head of Radioimmunology, Helmholtz-Zentrum Dresden, Germany
Head of Tumor Immunology, University Cancer Center (UCC), University Hospital ‘Carl Gustav Carus‘, Technical University Dresden, Germany
Deputy Head of the Working Group Tumor Immunology of the German Society for Immunology (Deutsche Gesellschaft für Immunologie, DGfI)
More than 190 scientific publications in peer-reviewed journals